NEW YORK, Nov. 6, 2016 /PRNewswire/ -- Rosen Law Firm, a
global investor rights law firm, announces that it has filed a
class action lawsuit on behalf of purchasers of the American
Depositary Shares ("ADSs") of Teva Pharmaceutical Industries
Limited (NYSE: TEVA) between February 10,
2015 and November 3, 2016,
both dates inclusive (the "Class Period"). The lawsuit seeks
recovery of investor losses.
To join the Teva class action, go to the website at
http://www.rosenlegal.com/cases-979.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or
email pkim@rosenlegal.com or kchan@rosenlegal.com for information
on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period Defendants
made false and/or misleading statements and/or failed to disclose
that: (1) Teva was engaging and/or had engaged in conduct that
would result in an antitrust investigation by the U.S. Department
of Justice ("DOJ") and the State of Connecticut Office of the
Attorney General; (2) the DOJ investigation and the underlying
conduct could cause U.S. prosecutors to file criminal charges
against Teva by the end of 2016 for suspected price collusion; (3)
in turn, Teva lacked effective internal controls over financial
reporting; and (4) as a result, Teva's public statements were
materially false and misleading at all relevant times.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
January 5, 2017. If you wish to join
the litigation, go to: http://www.rosenlegal.com/cases-979.html or
to discuss your rights or interests regarding this class action,
please contact Phillip Kim or
Kevin Chan of Rosen Law Firm toll
free at 866-767-3653 or via email at pkim@rosenlegal.com or
kchan@rosenlegal.com.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Contact Information:
Laurence
Rosen, Esq.
Phillip Kim,
Esq.
Kevin Chan,
Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th
Floor
New York,
NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
Logo - http://photos.prnewswire.com/prnh/20160907/405060LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/rosen-law-firm-files-securities-class-action-lawsuit-against-teva-pharmaceutical-industries-limited---teva-300358118.html
SOURCE Rosen Law Firm, P.A.